Conatus liver drug shows positive results in mid-stage trial

(Reuters) - Conatus Pharmaceuticals Inc said its experimental drug, emricasan, succeeded in reducing the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro